[
    [
        {
            "time": "2021-02-24",
            "original_text": "英科医疗(300677.SZ)拟认购苏州济峰三号基金份额投资医疗健康等领域",
            "features": {
                "keywords": [
                    "英科医疗",
                    "认购",
                    "苏州济峰三号",
                    "基金",
                    "医疗健康"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "英科医疗(300677.SZ)拟认购苏州济峰三号基金份额投资医疗健康等领域",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-24",
            "original_text": "英科医疗(300677.SZ)：子公司拟参与认购苏州济峰三号股权投资合伙企业(有限合伙)份额",
            "features": {
                "keywords": [
                    "英科医疗",
                    "子公司",
                    "认购",
                    "苏州济峰三号",
                    "股权投资"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "英科医疗(300677.SZ)：子公司拟参与认购苏州济峰三号股权投资合伙企业(有限合伙)份额",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-02-24",
            "original_text": "英科医疗：参与认购苏州济峰三号股权投资合伙企业(有限合伙)份额",
            "features": {
                "keywords": [
                    "英科医疗",
                    "认购",
                    "苏州济峰三号",
                    "股权投资"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "英科医疗：参与认购苏州济峰三号股权投资合伙企业(有限合伙)份额",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-24",
            "original_text": "对话徐佳熹：阶段性回调是通过ETF或主动基金的配置机会，医药医疗板块享受估值溢价",
            "features": {
                "keywords": [
                    "徐佳熹",
                    "阶段性回调",
                    "ETF",
                    "主动基金",
                    "医药医疗",
                    "估值溢价"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "对话徐佳熹：阶段性回调是通过ETF或主动基金的配置机会，医药医疗板块享受估值溢价",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-24",
            "original_text": "339公司利润不断改善86家步入绩优股行列",
            "features": {
                "keywords": [
                    "公司利润",
                    "改善",
                    "绩优股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "339公司利润不断改善86家步入绩优股行列",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-02-24",
            "original_text": "全年业绩高增长股提前看，624股净利润增幅翻倍",
            "features": {
                "keywords": [
                    "全年业绩",
                    "高增长",
                    "净利润",
                    "增幅翻倍"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "全年业绩高增长股提前看，624股净利润增幅翻倍",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]